LINC00707 Regulates miR-382-5p/VEGFA Pathway to Enhance Cervical Cancer Progression

Figure 3

LINC00707 sponged miR-382-5p. (a) RT-PCR indicated miR-382-5p expression in cervical cancer. (b) miR-382-5p expression in cervical cancer cells (HT-3, HCC94, CaSki, C-33A, MS751, and HEKn cells). (c) Pearson analysis of LINC00707 and miR-382-5p in cervical cancer tissues. (d, e) miR-382-5p expression in C-33A and HT-3 cells infected with LV-LINC00707 or LINC00707 siRNA. (f) Binding sites between LINC00707 and miR-382-5p. (g, h) Luciferase activity was evaluated in C-33A and HT-3 cells cotransfected with LINC00707-WT or LINC00707-MUT reporter and miR-382-5p inhibitors or mimics. .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)